AVVINITY THERAPEUTICS LIMITED

Company number 09967702

Date	Type	Description	View / Download
31 Dec 2023	AD01	Registered office address changed from 66 Prescot Street Prescot Street London E1 8NN to 10 Lower Thames Street London EC3R 6AF on 31 December 2023	(2 pages)
31 Oct 2023	LIQ03	Liquidators' statement of receipts and payments to 5 September 2023	(23 pages)
14 Sep 2022	600	Appointment of a voluntary liquidator	(3 pages)
14 Sep 2022	RESOLUTIONS	Resolutions LRESEX ‐ Extraordinary resolution to wind up on 2022-09-06	(1 page)
14 Sep 2022	LIQ02	Statement of affairs	(11 pages)
12 Sep 2022	AD01	Registered office address changed from First Floor 5 Fleet Place London EC4M 7rd United Kingdom to 66 Prescot Street Prescot Street London E1 8NN on 12 September 2022	(2 pages)
21 Apr 2022	SH01	Statement of capital following an allotment of shares on 19 April 2022 GBP 939.344	(3 pages)
11 Mar 2022	PSC05	Change of details for Cos Holdings Ltd as a person with significant control on 11 March 2022	(2 pages)
10 Mar 2022	CH01	Director's details changed for Christopher Eric Lowe on 10 March 2022	(2 pages)
10 Mar 2022	AD01	Registered office address changed from First Floor Thavies Inn House 3-4 Holborn Circus London EC1N 2HA to First Floor 5 Fleet Place London EC4M 7rd on 10 March 2022	(1 page)
04 Mar 2022	AA	Total exemption full accounts made up to 31 December 2021	(10 pages) Download iXBRL
25 Jan 2022	CS01	Confirmation statement made on 24 January 2022 with updates	(4 pages)
07 Dec 2021	AA01	Current accounting period shortened from 31 July 2022 to 31 December 2021	(1 page)
02 Nov 2021	AA	Total exemption full accounts made up to 31 July 2021	(10 pages) Download iXBRL
28 Jun 2021	AA01	Current accounting period shortened from 31 December 2021 to 31 July 2021	(1 page)
14 Jun 2021	AP01	Appointment of Clare Elizabeth Terlouw as a director on 4 June 2021	(2 pages)
11 Jun 2021	TM01	Termination of appointment of Pauline Christine Stasiak as a director on 28 May 2021	(1 page)
28 May 2021	PSC07	Cessation of Centauri Therapeutics Limited as a person with significant control on 13 May 2021	(1 page)
28 May 2021	PSC02	Notification of Cos Holdings Ltd as a person with significant control on 13 May 2021	(2 pages)
12 Apr 2021	AA	Total exemption full accounts made up to 31 December 2020	(10 pages) Download iXBRL
11 Feb 2021	CS01	Confirmation statement made on 24 January 2021 with updates	(4 pages)
09 Nov 2020	AP01	Appointment of Dr Jonathan David Moore as a director on 1 November 2020	(2 pages)
09 Nov 2020	AP01	Appointment of Mr Nicholas James Staples as a director on 1 November 2020	(2 pages)
25 Sep 2020	MA	Memorandum and Articles of Association	(16 pages)
25 Sep 2020	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(2 pages)